Summit Therapeutics

Summit Therapeutics R&D per Employee

The R&D Spending per Employee of Summit Therapeutics (SMMT) as of Nov 22, 2026 is 568,969.81 USD. In the previous year, R&D Spending per Employee was 224,418.87 USD — a change of 153.53% (higher).

R&D per Employee

568,969.81USD

YoY

153.53%

Last updated:

R&D Spending per Employee of Summit Therapeutics is 2024 568,969.81 USD. R&D Spending per Employee of Summit Therapeutics was 2023 224,418.87 USD. It decreases by 153.53% higher compared to the previous year.

The Summit Therapeutics R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2017
141,962.26 USD
Jan 1, 2018
192,075.47 USD
Jan 1, 2019
146,452.83 USD
Jan 1, 2020
196,113.21 USD
Jan 1, 2021
318,264.15 USD
Jan 1, 2022
192,792.45 USD
Jan 1, 2023
224,418.87 USD
Jan 1, 2024
568,969.81 USD
The Summit Therapeutics R&D per Employee history
YEARR&D per EmployeeYoY
568,969.81USD+153.53%
224,418.87USD+16.40%
192,792.45USD-39.42%
318,264.15USD+62.29%
196,113.21USD+33.91%
146,452.83USD-23.75%
192,075.47USD+35.30%
141,962.26USD+98.63%
71,471.70USD+12.40%
63,584.91USD+61.86%
39,283.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

R&D Spending per Employee of Summit Therapeutics is 568,969.81 USD in 2024.

R&D Spending per Employee of Summit Therapeutics changed from 224,418.87 USD to 568,969.81 USD, representing a 153.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Summit Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Summit Therapeutics

All Key Metrics — Summit Therapeutics